Cytoplasmic ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer

Annals of Surgical Oncology

Volumn 20, Issue 3 SUPPL., 2013, Pages

  Wu, Heng Hsiung ^a   Chu, Ya Chiung ^b   Wang, Lee ^a   Tsai, Lung Hung ^a   Lee, Ming Ching ^c   Chen, Chi Yi ^d   Shieh, Shwn Huey ^d,e   Cheng, Ya Wen ^a,f   Lee, Huei ^a,f  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Taichung MetroHarbor Hospital   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; MESSENGER RNA; PROTEIN E6; PROTEIN P53; REDOX EFFECTOR FACTOR 1; TRANSCRIPTION FACTOR SP1; APEX1 PROTEIN, HUMAN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; SMALL INTERFERING RNA; TP53 PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; BINDING SITE; CANCER CELL; CANCER PATIENT; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CELL INVASION; CONTROLLED STUDY; DNA BINDING; EXPRESSION VECTOR; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MUTAGENESIS; NITROSATION; POINT MUTATION; PROMOTER REGION; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; UPREGULATION; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CANCER STAGING; CELL ADHESION; CELL MOTION; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYTOPLASM; GENETICS; IMMUNOPRECIPITATION; LUNG TUMOR; METABOLISM; MORTALITY; MUTATION; NEOPLASM RECURRENCE, LOCAL; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYTOPLASM; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84892784526     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2431-2     Document Type: Article

References (17)

1. Tell G, Damante G, Caldwell D, Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal. 2005;7:367-84.
2. Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, Yu JH, et al. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer. 2008;60:277-84.
3. Sheng Q, Zhang Y, Wang R, Zhang J, Chen B, Wang J, et al. Prognostic significance of APE1 cytoplasmic localization in human epithelial ovarian cancer. Med Oncol. 2012;29:1265-71.
4. Pines A, Perrone L, Bivi N, Romanello M, Damante G, Gulisano M, et al. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res. 2005;33:4379-94.
5. Salzano AM, Paron I, Pines A, Bachi A, Talamo F, Bivi N, et al. Differential proteomic analysis of nuclear extracts from thyroid cell lines. J Chromatogr B. 2006;833:41-50.
6. Puglisi F, Barbone F, Tell G, Aprile G, Pertoldi B, Raiti C, et al. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Oncol Rep. 2002;9:11-7.
7. Zaky A, Busso C, Izumi T, Chattopadhyay R, Bassiouny A, Mitra S, et al. Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res. 2008;36:1555-66.
8. Qu J, Liu GH, Huang B, Chen C. Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic Acids Res. 2007;35:2522-32.
9. Cheng YW, Wu MF, Wang J, Yeh KT, Goan YG, Chiou HL, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res. 2007;67:10686-93.
10. Wu HH, Cheng YW, Chang JT, Wu TC, Liu WS, Chen CY, et al. Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation. Oncogene. 2010;29:4330-40.
11. Chang JT. An economic and efficient method of RNAi vector constructions. Anal Biochem. 2004;334:199-200.
12. Fung H, Bennett RA, Demple B. Key role of downstream specificity protein 1 site in cell cycle-regulated transcription of the AP endonuclease APE1/APEX in NIH3T3. J Biol Chem. 2001;276:42011-7.
13. Angkeow P, Deshpande SS, Qi B, Liu YX, Park YC, Jeon BH et al. Redox factor: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis. Cell Death Differ. 2002;9:717-25.
14. Hold GL, El-Omar EM. Genetic aspects of inflammation and cancer. Biochem J. 2008;410:225-35.
15. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31:37-49.
16. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation- associated cancer. Nature. 2004;431:461-6.
17. Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C, et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature. 2009;462:104-7.